- call +1-201-465-4211
- email sales@mrinsights.biz
Nifedipine is a drug that belongs to the class of calcium channel blocker, which interrupts the movement of calcium in the walls of the arteries.
Scope of the Report:
This report focuses on the Nifedipine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Nifedipine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Bayer (Germany)
Actavis (USA)
Teva (Israel)
Pfizer (USA)
Shyndec (China)
Honglin (China)
Huanghai (China)
Yabao (China)
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Nifedipine Controlled Release Tablets
Nifedipine Extended Action Tablets
Market Segment by Applications, can be divided into
Primary Pulmonary Hypertension
Heart Failure
Others
There are 15 Chapters to deeply display the global Nifedipine market.
Chapter 1, to describe Nifedipine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Nifedipine, with sales, revenue, and price of Nifedipine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Nifedipine, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Nifedipine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Nifedipine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Nifedipine Introduction
1.2 Market Analysis by Type
1.2.1 Nifedipine Controlled Release Tablets
1.2.2 Nifedipine Extended Action Tablets
1.3 Market Analysis by Applications
1.3.1 Primary Pulmonary Hypertension
1.3.2 Heart Failure
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer (Germany)
2.1.1 Business Overview
2.1.2 Nifedipine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer (Germany) Nifedipine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Actavis (USA)
2.2.1 Business Overview
2.2.2 Nifedipine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Actavis (USA) Nifedipine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Teva (Israel)
2.3.1 Business Overview
2.3.2 Nifedipine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Teva (Israel) Nifedipine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer (USA)
2.4.1 Business Overview
2.4.2 Nifedipine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer (USA) Nifedipine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Shyndec (China)
2.5.1 Business Overview
2.5.2 Nifedipine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Shyndec (China) Nifedipine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Honglin (China)
2.6.1 Business Overview
2.6.2 Nifedipine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Honglin (China) Nifedipine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Huanghai (China)
2.7.1 Business Overview
2.7.2 Nifedipine Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Huanghai (China) Nifedipine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Yabao (China)
2.8.1 Business Overview
2.8.2 Nifedipine Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Yabao (China) Nifedipine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Nifedipine Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Nifedipine Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Nifedipine Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Nifedipine Manufacturer Market Share in 2017
3.3.2 Top 6 Nifedipine Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Nifedipine Market Analysis by Regions
4.1 Global Nifedipine Sales, Revenue and Market Share by Regions
4.1.1 Global Nifedipine Sales and Market Share by Regions (2013-2018)
4.1.2 Global Nifedipine Revenue and Market Share by Regions (2013-2018)
4.2 North America Nifedipine Sales and Growth Rate (2013-2018)
4.3 Europe Nifedipine Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Nifedipine Sales and Growth Rate (2013-2018)
4.5 South America Nifedipine Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Nifedipine Sales and Growth Rate (2013-2018)
5 North America Nifedipine by Countries
5.1 North America Nifedipine Sales, Revenue and Market Share by Countries
5.1.1 North America Nifedipine Sales and Market Share by Countries (2013-2018)
5.1.2 North America Nifedipine Revenue and Market Share by Countries (2013-2018)
5.2 United States Nifedipine Sales and Growth Rate (2013-2018)
5.3 Canada Nifedipine Sales and Growth Rate (2013-2018)
5.4 Mexico Nifedipine Sales and Growth Rate (2013-2018)
6 Europe Nifedipine by Countries
6.1 Europe Nifedipine Sales, Revenue and Market Share by Countries
6.1.1 Europe Nifedipine Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Nifedipine Revenue and Market Share by Countries (2013-2018)
6.2 Germany Nifedipine Sales and Growth Rate (2013-2018)
6.3 UK Nifedipine Sales and Growth Rate (2013-2018)
6.4 France Nifedipine Sales and Growth Rate (2013-2018)
6.5 Russia Nifedipine Sales and Growth Rate (2013-2018)
6.6 Italy Nifedipine Sales and Growth Rate (2013-2018)
7 Asia-Pacific Nifedipine by Countries
7.1 Asia-Pacific Nifedipine Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Nifedipine Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Nifedipine Revenue and Market Share by Countries (2013-2018)
7.2 China Nifedipine Sales and Growth Rate (2013-2018)
7.3 Japan Nifedipine Sales and Growth Rate (2013-2018)
7.4 Korea Nifedipine Sales and Growth Rate (2013-2018)
7.5 India Nifedipine Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Nifedipine Sales and Growth Rate (2013-2018)
8 South America Nifedipine by Countries
8.1 South America Nifedipine Sales, Revenue and Market Share by Countries
8.1.1 South America Nifedipine Sales and Market Share by Countries (2013-2018)
8.1.2 South America Nifedipine Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Nifedipine Sales and Growth Rate (2013-2018)
8.3 Argentina Nifedipine Sales and Growth Rate (2013-2018)
8.4 Colombia Nifedipine Sales and Growth Rate (2013-2018)
9 Middle East and Africa Nifedipine by Countries
9.1 Middle East and Africa Nifedipine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Nifedipine Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Nifedipine Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Nifedipine Sales and Growth Rate (2013-2018)
9.3 UAE Nifedipine Sales and Growth Rate (2013-2018)
9.4 Egypt Nifedipine Sales and Growth Rate (2013-2018)
9.5 Nigeria Nifedipine Sales and Growth Rate (2013-2018)
9.6 South Africa Nifedipine Sales and Growth Rate (2013-2018)
10 Global Nifedipine Market Segment by Type
10.1 Global Nifedipine Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Nifedipine Sales and Market Share by Type (2013-2018)
10.1.2 Global Nifedipine Revenue and Market Share by Type (2013-2018)
10.2 Nifedipine Controlled Release Tablets Sales Growth and Price
10.2.1 Global Nifedipine Controlled Release Tablets Sales Growth (2013-2018)
10.2.2 Global Nifedipine Controlled Release Tablets Price (2013-2018)
10.3 Nifedipine Extended Action Tablets Sales Growth and Price
10.3.1 Global Nifedipine Extended Action Tablets Sales Growth (2013-2018)
10.3.2 Global Nifedipine Extended Action Tablets Price (2013-2018)
11 Global Nifedipine Market Segment by Application
11.1 Global Nifedipine Sales Market Share by Application (2013-2018)
11.2 Primary Pulmonary Hypertension Sales Growth (2013-2018)
11.3 Heart Failure Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Nifedipine Market Forecast (2018-2023)
12.1 Global Nifedipine Sales, Revenue and Growth Rate (2018-2023)
12.2 Nifedipine Market Forecast by Regions (2018-2023)
12.2.1 North America Nifedipine Market Forecast (2018-2023)
12.2.2 Europe Nifedipine Market Forecast (2018-2023)
12.2.3 Asia-Pacific Nifedipine Market Forecast (2018-2023)
12.2.4 South America Nifedipine Market Forecast (2018-2023)
12.2.5 Middle East and Africa Nifedipine Market Forecast (2018-2023)
12.3 Nifedipine Market Forecast by Type (2018-2023)
12.3.1 Global Nifedipine Sales Forecast by Type (2018-2023)
12.3.2 Global Nifedipine Market Share Forecast by Type (2018-2023)
12.4 Nifedipine Market Forecast by Application (2018-2023)
12.4.1 Global Nifedipine Sales Forecast by Application (2018-2023)
12.4.2 Global Nifedipine Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Nifedipine Picture
Table Product Specifications of Nifedipine
Figure Global Sales Market Share of Nifedipine by Types in 2017
Table Nifedipine Types for
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
